Sechenov University will use quantum technologies to accelerate drug development
21 February 2024
The drug created for the urgent treatment of tick-borne encephalitis has successfully finished its clinical trials, as declared by Vladimir Koval, the acting director of the Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the RAS.
Inhalable dry powder drug formulation could treat respiratory infections
20 February 2024
The drug formulation study offers promise for treating different respiratory tract infections using a single antimicrobial agent, a paper reports.
Smartphone app uses AI to potentially detect symptoms of stroke
20 February 2024
An artificial intelligence-enabled smartphone application developed to detect symptoms of stroke accurately evaluated facial asymmetry, arm weakness and speech changes in line with stroke onset, a speaker reported.
Clinical trials of a Russian drug against tick-borne encephalitis have been completed
19 February 2024
The drug created for the urgent treatment of tick-borne encephalitis has successfully finished its clinical trials, as declared by Vladimir Koval, the acting director of the Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the RAS.
Pharmaceutical suspension market to witness accelerated growth
19 February 2024
The global pharmaceutical suspensions market is set to value $83.8 billion by 2032, due to the systems having key benefits such as supporting patient compliance. A report by Allied Market Research predicts that the global pharmaceutical suspension market will reach $83.8 billion by 2032.
A genome database of 100 thousand Russians will be created by the end of 2025
16 February 2024
By the end of 2025, Russia will have a database of genomes of 100 thousand people. At the moment, the center for whole genome sequencing has a scientific database containing more than 27 thousand genomes. Andrey Shishkin, vice president for energy, localization, and innovation at Rosneft, stated that nearly all developed countries around the globe possess databases containing anywhere from 30,000 to half a million genomes. There is a discussion taking place about the potential for organizing extensive bioinformatics research in the Russian Federation. The research would focus on identifying genetic markers for diseases by utilizing anonymized data from a newly created genome database.
Low-Dose Positron Emission Mammography Helps ID Breast Cancer
16 February 2024
Vivianne Freitas, M.D., from the University of Toronto, and colleagues examined the feasibility of low-dose PEM concurrent to magnetic resonance imaging (MRI) to identify breast cancer. Twenty-five female participants newly diagnosed with breast cancer underwent low-dose PEM with up to 185 MBq of fluorine 18-labeled fluorodeoxyglucose (18F-FDG). PEM images taken one and four hours following 18F-FDG injection were reviewed by two breast radiologists, unaware of the cancer location.
Russian TB mRNA vaccine successfully passed preclinical trials
15 February 2024
Scientists at the Scientific Center for Translational Medicine at Sirius University have successfully developed an RNA-based vaccine against tuberculosis. The vaccine has shown promising results in preclinical trials, demonstrating high immunogenicity and protective activity when administered to rodents.
Researchers show plugging a nanopore sensor with gold could help detect ovarian cancer
15 February 2024
Researchers at Virginia Commonwealth University have shown that a urine-based test could have the potential to become a simplified screening method for catching earlier cases of ovarian cancer.
Raman and machine learning show promise for online monitoring of bioreactors
14 February 2024
Researchers based in France have demonstrated a robust online Raman monitoring model for bioreactors, which combines Raman spectroscopy and machine learning (ML).
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Russia has expanded the mandatory health insurance program for 2024-2026
29 March 2024
Russian scientists have developed new TB vaccines for both injection and nasal administration.
29 March 2024
The overall mortality rate of the population in Russia decreased by 7% in 2023
28 March 2024
Russia to collaborate with Hungary and Serbia in nuclear medicine
28 March 2024